Research & Information

• Answer questions on virtually any topic - science, history, math, technology, culture
• Search the web for current news and up-to-date information
• Find and summarize peer-reviewed medical literature (PubMed)

Medical & Clinical

• Answer medical, clinical, pharmacology, and anatomy questions using a library of authoritative medical textbooks
• Search recent studies, guidelines, and clinical trials
• Explain diagnoses, treatments, mechanisms, and procedures

Document & File Creation

• Word documents (.docx) - reports, memos, letters, templates
• PowerPoint presentations (.pptx) - slide decks, pitch decks
• Excel spreadsheets (.xlsx) - data tables, formulas, charts
• PDFs - create, merge, split, extract text, OCR

Code & Computation

• Write, run, and debug code (Python, JavaScript, shell, and more)
• Data analysis and visualization
• Automate tasks with scripts

Images

• Generate original images, diagrams, and posters from descriptions
• Analyze images you upload

File Handling

• Read and process files you upload (PDFs, spreadsheets, docs, images)
• Convert between formats

Medical Library

• Internal medicine, cardiology, neurology, pulmonology
• Pharmacology and drug mechanisms
• Anatomy and physiology
• Pathology and microbiology
• Surgery, OB/GYN, pediatrics, psychiatry, and more

Clinical Questions

• Explain diseases - pathophysiology, presentation, diagnosis, management
• Drug mechanisms, dosing, interactions, side effects
• Interpret lab values, imaging findings, ECGs
• Walk through clinical scenarios step by step
• Differential diagnosis support

Evidence-Based Research

• Search PubMed for peer-reviewed studies, meta-analyses, RCTs, and systematic reviews
• Fetch full-text papers and summarize findings
• Surface recent guidelines (e.g. AHA, WHO, NICE)
• Flag when new evidence may contradict older textbook content

Document Output

• Generate a clinical summary, drug monograph, or patient education sheet as a Word doc, PDF, or PowerPoint
• Build structured study notes or flashcard-style content for medical students

• I provide educational and reference information - not personal medical advice
• For patient care decisions, always verify against current institutional guidelines
• I'll always tell you when I'm uncertain rather than guess

Clinical Assessment: Unilateral Head/Face Pain + BP 150/90 + GBS 345 mg/dL

Immediate Red Flag Recognition

Top Differential Diagnoses

1. Pheochromocytoma (Pheo) - Must Exclude First

• Episodic/severe headache
• Hypertension
• Hyperglycemia (catecholamines cause glycogenolysis and inhibit insulin release)

2. Hypertensive Headache / Hypertensive Urgency

3. Cluster Headache (Trigeminal Autonomic Cephalalgia - TAC)

4. Diabetic Emergency with Headache

5. Intracranial Hypertension / CVT / Hemorrhage

Recommended Immediate Workup

Key Questions to Ask the Patient

• Any sweating, palpitations, or feeling of doom with the headache? (pheo)
• Is the eye red or tearing on the painful side? (cluster headache/TAC)
• Known diabetic? On any medications?
• Did the headache come on suddenly like a "thunderclap"? (subarachnoid hemorrhage - emergency)
• Any visual changes or neck stiffness?

Summary

Sources: Harrison's Principles of Internal Medicine 22E (2025); Barash's Clinical Anesthesia 9e; Campbell-Walsh Urology; Rosen's Emergency Medicine

Clinical Assessment: Known DM + HTN | Giddiness + Lower Limb Numbing/Painful | HbA1c 10%

Diagnosis: Diabetic Peripheral Neuropathy (DPN) + Likely Autonomic Neuropathy

Understanding the Two Symptoms

1. Lower Limb Numbing / Painful Sensation

"Sensory axons are more severely affected than motor axons, resulting in a clinical presentation dominated by paresthesias and numbness... accumulation of advanced glycosylation end products due to hyperglycemia, increased levels of reactive oxygen species, microvascular changes, and changes in axonal metabolism have all been implicated."

"Painful diabetic neuropathy is usually intermittent and worse at night. It can be experienced variably as pins and needles, throbbing, burning, aching, or cramping."

2. Giddiness (Dizziness)

Why HbA1c 10% is the Core Problem

"The Diabetes Control and Complications Trial demonstrated a 60% reduction in risk of developing neuropathy with tight glycemic control, which persisted for 8 years."

Management Plan

A. Glycemic Optimization (Most Important)

• Review current antidiabetic regimen - is the patient on metformin, sulfonylurea, insulin?
• Consider adding/intensifying:
  • SGLT-2 inhibitor (e.g., dapagliflozin) - a 2025 systematic review (PMID: 40612436) shows dapagliflozin combined with methylcobalamin significantly benefits DM with peripheral neuropathy
  • GLP-1 agonist (e.g., semaglutide) - also beneficial for weight and CV risk
• Target HbA1c: <7% if tolerated, <8% in elderly/comorbid patients

B. BP Control

• Target BP in diabetics: <130/80 mmHg (ADA guidelines)
• Preferred agents: ACE inhibitor or ARB - these also protect kidneys (nephroprotective), which is critical in diabetics
• Avoid over-treating BP if the giddiness is orthostatic - it could worsen

C. Painful Neuropathy - Symptomatic Treatment

Note: NSAIDs are relatively contraindicated in diabetics (renal and cardiac risk) - per Tintinalli's.

D. Autonomic Neuropathy / Giddiness

• Check orthostatic BP: lying → standing BP drop >20 mmHg systolic = orthostatic hypotension
• If confirmed:
  • Advice: rise slowly, dangle legs before standing, avoid dehydration
  • Compression stockings
  • Fludrocortisone or midodrine in refractory cases
• If giddiness is glucose-related: check pre/postprandial glucose log

E. Neuropathy Prevention / Monitoring

• Foot care education - critical. Numbness = loss of protective sensation = risk of silent ulcers, infections, and ultimately amputation
• Regular foot inspection (daily by patient, every 3 months by clinician)
• Monofilament test at every visit to track progression
• Nerve conduction study (NCS/EMG) if diagnosis needs confirmation or to track severity

Summary Box

Sources: Robbins & Kumar Basic Pathology; Tintinalli's Emergency Medicine; Harrison's Principles of Internal Medicine 22E (2025); Kaplan & Sadock's Psychiatry; Recent PubMed: PMID 40612436 (dapagliflozin + methylcobalamin in DPN, 2025 systematic review)

━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
         CLINICAL MANAGEMENT PLAN
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
Date        : 05 June 2026
Setting     : Outpatient / OPD
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━

PATIENT SUMMARY
---------------
Background  : Known Type 2 Diabetes Mellitus + Hypertension
Complaints  : Giddiness, bilateral lower limb numbing/painful
              sensation
Vitals      : BP 150/90 mmHg
Ix          : HbA1c 10% (all other tests within normal limits)

WORKING DIAGNOSES
-----------------
1. Diabetic Distal Symmetric Polyneuropathy (DPN)
   - Poorly controlled DM (HbA1c 10%) driving ongoing
     nerve damage via advanced glycosylation end-products,
     oxidative stress, and microvascular injury
   - Stocking-and-glove distribution, length-dependent
     dying-back neuropathy

2. Diabetic Autonomic Neuropathy (likely cause of giddiness)
   - Loss of autonomic vascular tone → orthostatic
     hypotension → positional dizziness

3. Uncontrolled Hypertension in a Diabetic
   - Target organ risk: renal, retinal, cardiovascular,
     neurological

━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
MANAGEMENT PLAN
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━

1. GLYCEMIC OPTIMIZATION  [PRIORITY #1]
---------------------------------------
Target    : HbA1c < 7.0% (< 8.0% if elderly/frail)
           Fasting BG: 80-130 mg/dL
           Post-prandial BG: < 180 mg/dL

Review current regimen. Consider:

  a) Metformin (if not already on it and eGFR allows)
     - 500 mg BD with meals, uptitrate to 1000 mg BD
     - Note: Metformin long-term use depletes Vitamin B12
       → check B12 levels, supplement if low

  b) Add SGLT-2 Inhibitor (preferred in DM + HTN + DPN)
     - Dapagliflozin 10 mg OD
     - Dual benefit: glycemic control + CV/renal protection
     - Bonus: 2025 systematic review supports
       dapagliflozin + methylcobalamin combination in DPN
       (PMID: 40612436)

  c) Add GLP-1 Receptor Agonist if BMI elevated
     - Semaglutide 0.5 mg SC weekly (uptitrate as tolerated)
     - Benefits: HbA1c reduction, weight loss, CV protection

  d) If insulin-naive and HbA1c remains >9% after 3 months:
     - Initiate Basal Insulin (Insulin Glargine 10 units SC
       at bedtime, titrate by 2 units every 3 days to
       fasting BG target)


2. BLOOD PRESSURE CONTROL
---------------------------
Target    : < 130/80 mmHg (ADA / ESC guidelines for DM)
           (Caution: avoid aggressive lowering if
            orthostatic hypotension confirmed)

  a) First-line (mandatory in diabetic with HTN):
     - ACE Inhibitor: Ramipril 5 mg OD (uptitrate to 10 mg)
       OR
     - ARB: Telmisartan 40-80 mg OD
     - Rationale: nephroprotective, anti-proteinuric,
       reduces cardiovascular mortality in DM

  b) If BP not at target on ACEi/ARB alone:
     - Add Amlodipine 5 mg OD (CCB - good add-on in DM)

  c) Monitor: renal function (creatinine, eGFR, K+)
     at 1 week and 4 weeks after starting ACEi/ARB


3. PAINFUL NEUROPATHY - SYMPTOM MANAGEMENT
--------------------------------------------
Goal: Reduce neuropathic pain, improve sleep and function

  FIRST-LINE (choose one):

  a) Duloxetine (SNRI)             [Preferred if comorbid
     - Start: 30 mg OD x 1 week     depression/anxiety]
     - Uptitrate: 60 mg OD
     - Maximum: 120 mg OD
     - Caution: avoid if severe hepatic impairment

  b) Pregabalin (Gabapentinoid)    [Preferred if sleep
     - Start: 75 mg BD              disturbance prominent]
     - Uptitrate to 150 mg BD
     - Maximum: 300 mg BD
     - Caution: dose-adjust for eGFR < 60 mL/min
     - Side effects: drowsiness, weight gain

  c) Gabapentin (alternative to pregabalin)
     - 300 mg OD, uptitrate to 300 mg TDS over 1-2 weeks

  SECOND-LINE (add-on or if above not tolerated):

  d) Amitriptyline 10-25 mg at night
     - Check baseline ECG (QTc) before starting
     - Avoid in elderly (fall risk, anticholinergic)

  e) Venlafaxine 37.5-75 mg OD (alternative SNRI)

  ADJUNCTS:
  f) Methylcobalamin (B12) 500 mcg TDS
     - Supports nerve repair; especially important if on
       long-term metformin (known to deplete B12)

  g) Capsaicin 0.075% cream topically BD-TDS
     - For focal burning pain; avoid on broken skin

  AVOID: NSAIDs (contraindicated - renal and CV risk in DM)


4. GIDDINESS / AUTONOMIC NEUROPATHY
-------------------------------------
  a) Confirm orthostatic hypotension:
     - Measure BP lying → 1 min standing → 3 min standing
     - Orthostatic hypotension = drop > 20 mmHg systolic
       or > 10 mmHg diastolic on standing

  b) Non-pharmacological (first-line):
     - Rise slowly from sitting/lying positions
     - Dangle legs at bedside before standing
     - Increase fluid and salt intake (if no HF/CKD)
     - Compression stockings (thigh-high, 30-40 mmHg)
     - Elevate head of bed 10-20 degrees at night
     - Avoid large carbohydrate-heavy meals

  c) Pharmacological (if non-pharm fails):
     - Fludrocortisone 0.1 mg OD (mineralocorticoid)
       Caution: monitor BP, K+, edema
       OR
     - Midodrine 2.5 mg TDS (alpha-1 agonist)
       Caution: supine hypertension; avoid at bedtime

  d) Also rule out: hypoglycemia as cause of giddiness
     - Review BG log, especially post-dose of insulin/
       sulfonylurea
     - If on sulfonylurea, consider switching to DPP-4i
       or SGLT-2i (lower hypoglycemia risk)


5. NEUROPATHY MONITORING & FOOT CARE  [Critical]
--------------------------------------------------
  - Monofilament test (10-g Semmes-Weinstein) at every visit
  - Vibration sense (128 Hz tuning fork) at great toe
  - Ankle reflexes
  - Nerve Conduction Study (NCS/EMG): baseline if not
    done, repeat annually if abnormal

  Foot Care Education (mandatory):
  - Inspect feet daily (use mirror for soles)
  - Never walk barefoot
  - Moisturize feet (avoid between toes)
  - Properly fitting footwear; avoid tight socks
  - Report any non-healing wound, blister, or discoloration
    immediately
  - Referral to podiatry if high-risk foot features present


6. INVESTIGATIONS TO ORDER NOW
--------------------------------
  [ ] Fasting lipid profile (cardiovascular risk in DM+HTN)
  [ ] Urine ACR (albumin:creatinine ratio) - screen for
      diabetic nephropathy
  [ ] Serum creatinine + eGFR
  [ ] Serum electrolytes (K+ before starting ACEi)
  [ ] Vitamin B12 level (if on long-term metformin)
  [ ] Thyroid function (TSH) - hypothyroidism mimics DPN
  [ ] Postural BP measurement (lying and standing)
  [ ] Fundoscopy / ophthalmology referral (diabetic
      retinopathy screening)
  [ ] ECG (baseline; needed if starting amitriptyline)


7. FOLLOW-UP SCHEDULE
-----------------------
  2 weeks   : Review BP response, check renal function
              after ACEi, assess side effects of new meds
  4 weeks   : BG diary review, neuropathy symptom score,
              postural BP, K+ and creatinine recheck
  3 months  : Repeat HbA1c, medication titration
  6 months  : Repeat lipid profile, urine ACR, foot exam
  Annually  : HbA1c, lipids, eGFR, urine ACR, eye review,
              NCS if neuropathy progressing


8. REFERRALS
-------------
  - Diabetologist / Endocrinology: for intensive glycemic
    management if HbA1c not improving
  - Neurology: if NCS abnormal or neuropathy atypical
  - Ophthalmology: annual diabetic retinopathy screen
  - Podiatry: foot care and ulcer prevention
  - Dietitian: carbohydrate-controlled, low-sodium diet
    plan for DM + HTN

━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
CLINICAL PEARLS
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
1. Every 1% reduction in HbA1c = ~35% reduction in
   microvascular complications (UKPDS data).

2. In a diabetic with giddiness + HTN, always check
   postural BP before intensifying antihypertensives -
   over-treating can worsen orthostatic hypotension.

3. Metformin + B12 deficiency is under-recognised.
   B12 depletion worsens neuropathy independently of
   glucose control. Always check and supplement.

4. Duloxetine is preferred over pregabalin if the
   patient has comorbid depression - dual benefit.
   Pregabalin is preferred if the pain is disrupting
   sleep.

5. Foot ulcers in a numb foot = silent emergency.
   Educate firmly and early - amputation prevention
   starts at the clinic visit.

━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
REFERENCES
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
- Harrison's Principles of Internal Medicine, 22E (2025)
- Tintinalli's Emergency Medicine, 9E
- Robbins & Kumar Basic Pathology
- Kaplan & Sadock's Comprehensive Textbook of Psychiatry
- PMID 40612436: Dapagliflozin + methylcobalamin in T2DM
  with peripheral neuropathy (Systematic Review, 2025)
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━

Insulin Dosing Plan - Human Actrapid (Regular Human Insulin)

Patient Profile

• Weight: 80-100 kg (use 90 kg as midpoint for calculation)
• HbA1c: 10% (poorly controlled T2DM)
• Insulin: Human Actrapid (short-acting regular insulin, SC)
• Status: Insulin-naive

Step 1 - Calculate Total Daily Dose (TDD)

TDD = 0.3 to 0.5 units/kg/day

At 90 kg:
  Conservative start : 0.3 × 90 = 27 units/day
  Standard start     : 0.4 × 90 = 36 units/day
  Higher if HbA1c >9%: 0.5 × 90 = 45 units/day

Given HbA1c = 10% → use 0.4-0.5 units/kg
→ TDD = 36 to 45 units/day  (round to ~40 units/day)

Step 2 - Split the TDD (Actrapid = Prandial Insulin)

Option A - Actrapid Alone (TDS Before Meals)

TDD ÷ 3 meals = 40 ÷ 3 ≈ 12-14 units per meal

Actrapid 12 units SC  →  30 min before breakfast
Actrapid 12 units SC  →  30 min before lunch
Actrapid 12 units SC  →  30 min before dinner

Note: This covers only post-meal spikes. Fasting glucose will remain uncontrolled without a basal insulin.

Option B - Actrapid + NPH (Recommended - More Physiological)

TDD = 40 units

Morning dose (2/3 of TDD = 27 units):
  ├─ Actrapid (1/3 of morning) = 9 units   → before breakfast
  └─ NPH     (2/3 of morning) = 18 units   → before breakfast

Evening dose (1/3 of TDD = 13 units):
  ├─ Actrapid (1/2 of evening) = 6-7 units → before dinner
  └─ NPH      (1/2 of evening) = 6-7 units → before dinner

Step 3 - Per Meal Prandial Dose Formula

"The initial dose of any prandial rapid-acting insulin can be approximated as 0.1 unit/kg per meal."

0.1 × 90 kg = 9 units per meal

→ Actrapid 8-10 units SC, 30 minutes before each meal

Step 4 - Titration Protocol

Step 5 - Practical Dosing Summary (for this patient)

━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
 STARTING INSULIN ORDER - HUMAN ACTRAPID
 Patient weight: ~90 kg | HbA1c: 10%
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━

 Actrapid 10 units SC  30 min before breakfast
 Actrapid 10 units SC  30 min before lunch
 Actrapid 10 units SC  30 min before dinner

 Total starting dose = 30 units/day

 Titrate: increase by 2 units every 3 days
          if fasting BG remains > 130 mg/dL

 Target: Fasting BG 80-130 mg/dL
         2-hr post-meal BG < 180 mg/dL

━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━

Critical Safety Points

Sources: Textbook of Family Medicine 9e; Goldman-Cecil Medicine; Harrison's 22E (2025)